Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1Head and Neck Neoplasms 1

Interventions

Tobacco Use Cessation Devices 5Counseling 5Early Intervention, Educational 3Bupropion 3Varenicline 2Nicotine Replacement Therapy 2Nicotine 2Community Health Workers 2Aspirin 2zileuton 1phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1Sulindac 1Risk Factors 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Methods 1Memantine 1Gene Expression Profiling 1Fertility 1Ethanol 1Drug Therapy 1Celecoxib 1Calcitriol 14-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tobacco Use Disorder × phenethyl isothiocyanate × Clear all
NCT00691132 2017-05-12

Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers

University of Minnesota

Phase 2 Completed
107 enrolled 18 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tobacco Use Disorder, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡